As of Oct 2, 2026 close
- Market cap
- $218.39M
- P/E (TTM)
- —
- Forward P/E
- —
- Dividend yield
- —
- 52-week range
- $3.08$16.34
- Volume (live)
- —
- Avg. volume (3M)
- 280.42K
Armata Pharmaceuticals (ARMP) Stock Price & Financial Analysis
Armata Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.32 - $3.55 |
|---|---|
| 52-Week High | $16.34 |
| 52-Week Low | $3.08 |
| Open | $3.40 |
| Volume (last close) | 123.85K |
| Average Volume (3M) | 280.42K |
| Market Cap | 218.39M |
|---|---|
| Shares Outstanding | 62.04M |
| Price to Sales (P/S) | 66.20 |
| Price to Book (P/B) | -0.94 |
| EV/EBITDA | -1.95 |
| Revenue (TTM) | 3.30M |
|---|---|
| Net Income (TTM) | -192.18M |
| Free Cash Flow (TTM) | -25.79M |
| EPS (TTM) | $-4.49 |
| Profit Margin | -5825.34% |
| Operating Margin | -1069.54% |
| 50-Day MA | $4.69 |
|---|---|
| 200-Day MA | $7.31 |
| 52-Week Change | +14.70% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Armata Pharmaceuticals at a Glance
Armata Pharmaceuticals (ARMP) has a market capitalization of $218.39M. The stock trades at 66.2× sales. Over the trailing twelve months it lost $192.18M on revenue of $3.30M and burned $25.79M of free cash flow. Revenue fell 52.0% year over year.
It holds $23.95M in cash and securities against $313.95M of debt, a net debt position of $290.00M.
Armata Pharmaceuticals does not currently pay a dividend.
The share price is up 12.8% over the past year. At $3.52 it sits near the bottom of its 52-week range of $3.08 to $16.34, below its 200-day moving average of $7.31.
Frequently Asked Questions About Armata Pharmaceuticals
What is the current stock price for ARMP?
As of the Oct 2, 2026 close, ARMP stock trades at $3.52. The 52-week range is $3.08–$16.34, with a day range of $3.32–$3.55.
What is the P/E ratio for ARMP?
The P/E ratio (Price-to-Earnings) for ARMP is shown in the Key Statistics section. This valuation metric helps compare Armata Pharmaceuticals, Inc. to industry peers.
Does ARMP pay dividends?
Armata Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ARMP?
Analyst ratings and recommendations for ARMP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ARMP?
Armata Pharmaceuticals's market capitalization is $218.4M, classifying it as a micro-cap company. Armata Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.